Assay News and Research

RSS

Urine-based DNA test predicts bladder cancer recurrence after immunotherapy

In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for recurrence after treatment.

30 Jun 2025

Beetle-inspired tuberculosis testing device offers accurate detection for people with HIV

Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB from traditional tests by eliminating the immune cells relied upon to sound the alarm.

27 Jun 2025

Study shows polar winter challenges men’s muscle mass but not hormone levels

Researchers tracked testosterone, cortisol, and body composition in 23 men overwintering at Concordia Station, Antarctica. Despite extreme polar conditions, hormone levels remained stable, though nearly half the crew experienced significant muscle loss.

26 Jun 2025

One in six cancer medications fails safety standards in sub-Saharan Africa

Serious quality defects were found in a significant number of cancer medications from sub-Saharan Africa, according to new research from the University of Notre Dame.

26 Jun 2025

Tirzepatide rewires appetite and slashes calorie intake in new obesity trial

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain imaging revealed that tirzepatide also lowered neural responses to high-fat, high-sugar food cues, offering mechanistic insight into its potent weight-loss effects.

25 Jun 2025

Mursla Bio introduces AI Precision Medicine Platform built on organ-specific EV isolation from blood

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly improve cancer outcomes for at-risk patients, today announced the commercial launch of its AI Precision Medicine Platform, alongside a pre-print reporting the first validated method for isolating hepatocyte EVs from plasma for organ-specific proteomic and miRNA profiling. Mursla Bio is engaging with potential partners to apply its Platform to additional disease areas, biomarker discovery and IV

17 Jun 2025

New nanopore sequencing assay advances fragile X syndrome carrier screening

Researchers have developed an innovative new nanopore sequencing assay to identify carriers of fragile X syndrome (FXS), the leading cause of monogenic autism spectrum disorder and inherited intellectual disabilities.

12 Jun 2025

How Fluidics is Powering Modern Healthcare and Medical Device Innovation

The future of fluidics in healthcare: Blake Webb shares trends in automation and microfluidics that are reshaping medical diagnostics and laboratory processes.

From Fluid Metering, Inc. 12 Jun 2025

CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development

CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system (MPS) models that enhance translatability in preclinical drug safety and toxicology assessments to its Contract Research Services (CRS). Building upon the Company's FDA-recognized drug induced liver injury (DILI) assay, the expanded offering enables rapid, comparative studies between commonly used animal and human models to flag interspecies differences early, and better informs in vivo study design.

10 Jun 2025

Glycan mapping reveals what keeps the vaginal microbiome healthy

Glycan-bacteria binding profiles in the vaginal microbiome provide insights into reproductive health, highlighting targets for infection prevention strategies.

9 Jun 2025

Compact diagnostic platform enables rapid COVID-19 antibody testing from fingertip blood

Researchers from the Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, along with multiple collaborators, have developed a compact diagnostic platform that can evaluate antibody protection against COVID-19 using only a single microliter of fingertip blood.

5 Jun 2025

Individual immune variation shapes the evolution of influenza strains

A new study has shown that person-to-person variation in antibody immunity plays a key role in shaping which influenza (flu) strains dominate in a population.

3 Jun 2025

Fujifilm rebrands Life Sciences Companies to strengthen position as strategic partners for life, offering end-to-end solutions

FUJIFILM Corporation's Life Sciences Group companies, a portfolio of businesses offering products, services and comprehensive solutions that span all stages of therapeutic development from discovery through to commercialization, today announced new names and identities as part of a strategic positioning effort.

3 Jun 2025

New microfluidic device brings affordable kidney testing to the point of care

Chronic kidney disease (CKD) affects over 800 million people globally and is often diagnosed too late for effective intervention.

31 May 2025

Heavy smoking triggers systemic inflammation and vascular damage in new biomarker study

Heavy smoking in adult males significantly increases oxidative stress, inflammation, and vascular dysfunction, as shown by comprehensive blood and tissue biomarker analysis. The findings highlight measurable biological damage and reinforce the urgent need for targeted public health interventions.

26 May 2025

Sartorius launches the Octet® R8e System: Real-time, label-free biomolecular interaction analysis with unprecedented sensitivity and efficiency

The life science group Sartorius launches the new Octet® R8e biolayer interferometry (BLI) system, providing researchers with its most advanced detection capabilities to date for real-time, high-throughput analysis of protein-protein, protein-small molecule, and other biomolecular interactions.

24 May 2025

Advancing GPCR drug discovery with fragment screening using GCI technology

Evotec's insights into GPCRs and waveRAPID technology reveal new opportunities in drug discovery, focusing on orphan receptors and innovative screening methods.

From Creoptix (A Malvern Panalytical brand) 23 May 2025

Air pollution’s chemical punch alters immune markers in pregnant women, study finds

Personal exposure to nitrogen dioxide and the oxidative potential of fine particulate matter (PM2.5), but not PM2.5 mass, influenced immune biomarker levels in pregnant women. These findings suggest that the chemical reactivity of air pollutants may play a key role in maternal and fetal immune health.

22 May 2025

Cutting back on sugary drinks may protect men’s fertility, review finds

Regular consumption of sugar-sweetened beverages is associated with lower sperm count, motility, and increased DNA damage, potentially impairing male reproductive health. This narrative review highlights dose-response effects, mechanisms, and research gaps, calling for further studies on diverse populations.

22 May 2025

Nanoworx announces nanomedicine development and optimization services!

Nanoworx B.V., a Contract Research Organization specializing in nanomedicine, is thrilled to announce the launch of its comprehensive service portfolio for academic and industry partners.

22 May 2025

Assay News and Research

Urine-based DNA test predicts bladder cancer recurrence after immunotherapy

Beetle-inspired tuberculosis testing device offers accurate detection for people with HIV

Study shows polar winter challenges men’s muscle mass but not hormone levels

One in six cancer medications fails safety standards in sub-Saharan Africa

Tirzepatide rewires appetite and slashes calorie intake in new obesity trial

Mursla Bio introduces AI Precision Medicine Platform built on organ-specific EV isolation from blood

New nanopore sequencing assay advances fragile X syndrome carrier screening

How Fluidics is Powering Modern Healthcare and Medical Device Innovation

CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development

Glycan mapping reveals what keeps the vaginal microbiome healthy

Compact diagnostic platform enables rapid COVID-19 antibody testing from fingertip blood

Individual immune variation shapes the evolution of influenza strains

Fujifilm rebrands Life Sciences Companies to strengthen position as strategic partners for life, offering end-to-end solutions

New microfluidic device brings affordable kidney testing to the point of care

Heavy smoking triggers systemic inflammation and vascular damage in new biomarker study

Sartorius launches the Octet® R8e System: Real-time, label-free biomolecular interaction analysis with unprecedented sensitivity and efficiency

Advancing GPCR drug discovery with fragment screening using GCI technology

Air pollution’s chemical punch alters immune markers in pregnant women, study finds

Cutting back on sugary drinks may protect men’s fertility, review finds

Nanoworx announces nanomedicine development and optimization services!

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News